Blog
RSS FeedPosted by Michael Wonder on 16 Mar 2020
Shortcomings in the US pharmaceutical supply chain: potential risks associated with international manufacturing and trade-related tariffs
16 March 2020 - In 2016, an explosion at a factory of the Chinese industrial giant Qilu Pharmaceutical resulted in suspension ...
Posted by Michael Wonder on 16 Mar 2020
Chinese official warns against U.S. effort to limit foreign medicine supplies
17 March 2020 - A Chinese official on Monday warned that a push by the White House to reduce U.S. ...
Posted by Michael Wonder on 12 Mar 2020
Coronavirus spurs U.S. efforts to end China’s chokehold on drugs
11 March 2020 - The Trump administration says the U.S. is too dependent on China for vital drugs. But it’s unclear ...
Posted by Michael Wonder on 12 Mar 2020
Law makers pressure big pharma on drug supply chains amid coronavirus outbreak
11 March 2020 - Law makers have for years been concerned the U.S. is too reliant on foreign manufacturing of medicine. ...
Posted by Michael Wonder on 04 Mar 2020
Drug shortages in the United States. Are some prices too low?
3 March 2020 - The US public identified lowering prescription drug prices as the top health priority for Congress in 2019. ...
Posted by Michael Wonder on 05 Feb 2020
Orsini Pharmaceutical Services now providing FDA approved Vyondys 53 (golodirsen) injection for Duchenne muscular dystrophy
5 February 2020 - Commercial distribution of Vyondys 53 in the U.S. is currently underway. ...
Posted by Michael Wonder on 20 Nov 2019
Generic drug approvals soar, but patients still go without
19 November 2019 - Brand name makers’ patent action limits release of the lower-price medicines, hindering cost-control efforts. ...
Posted by Michael Wonder on 07 Nov 2019
The U.S. insulin crisis — rationing a lifesaving medication discovered in the 1920s
7 November 2019 - The members of the team that discovered insulin sold the patent to the University of Toronto for ...
Posted by Michael Wonder on 05 Nov 2019
A severe shortage hits a drug used for cancer, immune disorders, epilepsy, causing canceled treatments and rationing
5 November 2019 - A severe shortage of immune globulin — a popular medicine used to treat epilepsy, cancer and ...
Posted by Michael Wonder on 29 Oct 2019
FDA issues new recommendations to combat drug shortages, but can it really fix the problem?
29 October 2019 - The growing number of drug shortages plaguing the U.S. health care system is due to what ...
Posted by Michael Wonder on 29 Oct 2019
Statement on FDA’s new report regarding root causes and potential solutions to drug shortages
29 October 2019 - One of the U.S. FDA’s top priorities is to ensure that Americans have access to safe ...
Posted by Michael Wonder on 17 Oct 2019
Have FDA actions to ease generic drug shortages taken effect yet?
16 October 2019 - On Wednesday, the FDA said fiscal year 2018 saw a record number of generic drug approvals. ...
Posted by Michael Wonder on 15 Oct 2019
Faced with a drug shortfall, doctors scramble to treat children with cancer
14 October 2019 - A critical chemotherapy medication is in short supply, and physicians say there is no appropriate substitute. ...
Posted by Michael Wonder on 14 Oct 2019
FDA bid to bolster generic competition and combat shortages isn’t working — yet
14 October 2019 - Although the FDA has maintained that additional generic approvals should promote competition and alleviate shortages, the ...
Posted by Michael Wonder on 08 Oct 2019
HIV prevention drugs will be available without a prescription in California
7 October 2019 - California will expand access to HIV prevention drugs by allowing pharmacies to offer the medications without ...